[1]
|
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu and T. Murray, “Cancer Statistics, 2008,” A Cancer Journal for Clinicians, Vol. 58, No. 2, 2008, pp. 71-96.
doi:10.3322/CA.2007.0010
|
[2]
|
N. N. Baxter, B. A. Virnig, S. B. Durham, et al., “Trends in the Treatment of Ductal Carcinoma in Situ of the Breast,” Journal of the National Cancer Institute, Vol. 96, No. 6, 2004, pp. 443-448. doi:10.1093/jnci/djh069
|
[3]
|
V. L. Katz and D. Detters, “Lentz: Comprehensive Gynecology Mosby an Imprint of Elsevier. Chapter 15. Diagnosis and Treatment of Benign and Malignant Breast Diseases,” 6th Edition, Elsevier, Philadelphia, 2012.
|
[4]
|
S. J. Katz, P. M. Lantz, N. K. Janz, et al., “Patient InVolvement in Surgery Treatment Decisions for Breast Cancer,” Journal of Clinical Oncology, Vol. 23, No. 24, 2005, pp. 5526-5533. doi:10.1200/JCO.2005.06.217
|
[5]
|
N. S. Williams, C. J. K. Bulstrode and P. R. O’Connell, “Bailey and Love’s Short Practice of Surgery Textbook,” 25th Edition, Edward Arnold, London, 2008.
|
[6]
|
M. Kaufmann, G. N. Hortobagyi, A. Goldhirsch, et al., “Recommendations from an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update,” Journal of Clinical Oncology, Vol. 24, No. 12, 2006, pp. 1940-1949.
doi:10.1200/JCO.2005.02.6187
|
[7]
|
H. D. Bear, S. Anderson, A. Brown, et al., “The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27,” Journal of Clinical Oncology, Vol. 21, No. 22, 2003, pp. 555-558. doi:10.1200/JCO.2003.12.005
|
[8]
|
P. Fobair, S. L. Stewart, S. Chang, C. D’Onofrio, P. J. Banks and J. R. Bloom, “Body Image and Sexual Problems in Young Women with Breast Cancer,” Psychooncology, Vol. 15, No. 7, 2006, pp. 579-594.
doi:10.1002/pon.991
|
[9]
|
M. Y. Nahabedian, “Breast Reconstruction: A Review and Rationale for Patient Selection,” Plastic and Reconstructive Surgery, Vol. 124, No. 1, 2009, pp. 55-62.
doi:10.1097/PRS.0b013e31818b8c23
|
[10]
|
J. Peppercorn, “Breast Cancer in Women under 40,” Oncology, Vol. 23, No. 6, 2009, pp. 465-474.
|
[11]
|
J. Y. Petit, M. Rietjens and C. Garusi, “Breast Reconstructive Techniques in Cancer Patients: Which Ones, When to Apply, Which Immediate and Long Term Risks?” Journal of Hematology & Oncology, Vol. 38, No. 3, 2001, pp. 231-239.
|
[12]
|
S. J. Kronovitz and G. L. Robb, “Controversies Regarding Immediate Reconstruction: Aesthetic Risks of Radiation,” In: S. L. Spear, Ed., Surgery of the Breast, 2nd Edition, Lippincott Williams & Wilkins, Philadelphia, 2006, pp. 679-699.
|
[13]
|
S. Al Benna, “Female Plastic and Reconstructive Surgeons’ Personal Decision Making for Breast Cancer Treatment and Reconstruction,” Archives of Gynecology and Obstetrics, Vol. 284, No. 3, 2011, pp. 737-741.
doi:10.1007/s00404-010-1721-9
|
[14]
|
A. K. Alderman, S. T. Hawley, J. Waljee, M. Mujahid, M. Morrow and S. J. Katz, “Understanding the Impact of Breast Reconstruction on the Surgical Decision-Making Process for Breast Cancer,” Cancer, Vol. 112, No. 3, 2008, pp. 489-494. doi:10.1002/cncr.23214
|
[15]
|
M. Marín-Gutzke and A. Sánchez-Olaso, “Reconstructive Surgery in Young Women with Breast Cancer,” Breast Cancer Research and Treatment, Vol. 123, Suppl. 1, 2010, pp. 67-74.
|